SBFM earnings

Sunshine Biopharma (SBFM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

SBFM earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 12, 2026-5.20-3.40-52.94%$9.44M
Q2 2026Aug 13, 2026-23.00-24.004.17%$9.26M
Q1 2026May 13, 2026-2.50-1.60-56.25%$8.09M
Q1 2026Apr 4, 2026-3.00-2.70-11.11%$8.09M
Q3 2025Nov 13, 2025-1.90-1.30-46.15%$9.42M
Q2 2025Aug 12, 2025-3.90-1.10-254.55%$9.41M
Q1 2025May 15, 2025-4.40––$8.90M
Q3 2024Nov 5, 2024-9.40-5350.0099.82%$8.44M
Q2 2024Aug 16, 2024-1988.00-148.00-1243.24%$9.30M
Q1 2024May 20, 2024-400.00-3200.0087.50%$7.54M
Q4 2023Mar 28, 2024-1000.00-1200.0016.67%$7.68M
Q3 2023Nov 13, 2023-800.00-2400.0066.67%$5.96M
Q2 2023Aug 11, 2023-400.00-3200.0087.50%$5.56M
Q1 2023May 10, 2023-1600.00––$4.89M
Q1 2023Apr 4, 2023-30000.00––$4.89M
Q3 2022Nov 7, 2022-1600.00––$132.81K